“…It also should be noted that many of those studies utilized the AOFAS Ankle-Hindfoot Scale, which is not a validated instrument, as a key outcome measure 11 ; as a consequence, the improvements should be interpreted with caution. Those Level-IV studies do not provide sufficient evidence (Grade-C recommendation) (Table II) to conclusively support the use of osteochondral allograft for the treatment of an osteochondral lesion of the talus of any size, location, grade, stability, displacement, or containment, or for the use of bipolar tibiotalar allografting 20 .…”